Home > Insider Trading > Filing (0001437749-20-015126)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1384101	Veracyte Inc.	VCYT	Services-Medical Laboratories (8071)	205455398

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1769333	C Giulia Kennedy	6000 Shoreline Court Suite 300 South San Francisco CA 94080	Chief Scientific & Med Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-07-13	13,498	$14.34	93,985	No	4	M	Direct
Common Stock	Acquisiton	2020-07-13	1,771	$9.05	95,756	No	4	M	Direct
Common Stock	Acquisiton	2020-07-13	1,469	$5.98	97,225	No	4	M	Direct
Common Stock	Disposition	2020-07-13	724	$28.82	96,501	No	4	S	Direct
Common Stock	Disposition	2020-07-13	15,814	$29.69	80,687	No	4	S	Direct
Common Stock	Disposition	2020-07-13	200	$30.46	80,487	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-07-13	13,498	$0.00	13,498	$14.34
Common Stock	Stock Option (right to buy)	Disposition	2020-07-13	1,771	$0.00	1,771	$9.05
Common Stock	Stock Option (right to buy)	Disposition	2020-07-13	1,469	$0.00	1,469	$5.98

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2	2024-02-18	No	4	M	Direct
14,167	2027-03-02	No	4	M	Direct
29,375	2028-03-01	No	4	M	Direct

Footnotes

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.
Represents weighted average sales price. Sale prices for the transactions range from $28.40 to $29.40. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $29.41 to $30.38. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $30.45 to $30.46. Detailed information regarding the number of shares sold at each separate price will be provided to theSEC, the issuer or a shareholder upon request.
The option is fully vested.
The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuousservice thereafter.
The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuousservice thereafter.